Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MOXIFLOXACIN Cause C-reactive protein abnormal? 170 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 170 reports of C-reactive protein abnormal have been filed in association with MOXIFLOXACIN (Moxifloxacin Hydrochloride Tablets, 400 mg). This represents 1.2% of all adverse event reports for MOXIFLOXACIN.

170
Reports of C-reactive protein abnormal with MOXIFLOXACIN
1.2%
of all MOXIFLOXACIN reports
139
Deaths
155
Hospitalizations

How Dangerous Is C-reactive protein abnormal From MOXIFLOXACIN?

Of the 170 reports, 139 (81.8%) resulted in death, 155 (91.2%) required hospitalization, and 139 (81.8%) were considered life-threatening.

Is C-reactive protein abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MOXIFLOXACIN. However, 170 reports have been filed with the FAERS database.

What Other Side Effects Does MOXIFLOXACIN Cause?

Drug hypersensitivity (2,013) Off label use (1,563) Dyspnoea (1,543) Drug ineffective (1,496) Vomiting (1,377) Pain (1,368) Asthma (1,342) Neuropathy peripheral (1,331) Rash (1,212) Pneumonia (1,172)

What Other Drugs Cause C-reactive protein abnormal?

METHOTREXATE (3,734) ADALIMUMAB (3,629) ETANERCEPT (3,592) ABATACEPT (3,402) LEFLUNOMIDE (3,279) TOCILIZUMAB (3,259) HYDROXYCHLOROQUINE (3,245) SULFASALAZINE (2,823) INFLIXIMAB (2,676) RITUXIMAB (2,608)

Which MOXIFLOXACIN Alternatives Have Lower C-reactive protein abnormal Risk?

MOXIFLOXACIN vs MOXIFLOXACIN\MOXIFLOXACIN MOXIFLOXACIN vs MOXONIDINE MOXIFLOXACIN vs MS CONTIN MOXIFLOXACIN vs MULTAQ MOXIFLOXACIN vs MULTIHANCE

Related Pages

MOXIFLOXACIN Full Profile All C-reactive protein abnormal Reports All Drugs Causing C-reactive protein abnormal MOXIFLOXACIN Demographics